Walgreens Boots Alliance Inc (NASDAQ:WBA) — Market Cap & Net Worth
Market Cap & Net Worth: Walgreens Boots Alliance Inc (WBA)
Walgreens Boots Alliance Inc (NASDAQ:WBA) has a market capitalization of $10.37 Billion ($10.37 Billion) as of July 31, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2151 globally and #810 in its home market, demonstrating a -1.80% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Walgreens Boots Alliance Inc's stock price $11.98 by its total outstanding shares 865561024 (865.56 Million). See Walgreens Boots Alliance Inc (WBA) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Walgreens Boots Alliance Inc Market Cap History: 2015 to 2025
Walgreens Boots Alliance Inc's market capitalization history from 2015 to 2025. Data shows change from $51.00 Billion to $10.37 Billion (-15.20% CAGR).
Index Memberships
Walgreens Boots Alliance Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$60.61 Trillion | 0.02% | #463 of 503 |
|
NASDAQ Composite
IXIC
|
$39.70 Trillion | 0.03% | #246 of 3165 |
|
S&P RETAIL SELECT INDUST
SPSIRE
|
$4.78 Trillion | 1.37% | #23 of 76 |
Weight: Walgreens Boots Alliance Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Walgreens Boots Alliance Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Walgreens Boots Alliance Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Walgreens Boots Alliance Inc's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $51.00 Billion | $103.44 Billion | $4.22 Billion | 0.49x | 12.09x |
| 2016 | $50.49 Billion | $117.35 Billion | $4.17 Billion | 0.43x | 12.10x |
| 2017 | $45.18 Billion | $118.21 Billion | $4.08 Billion | 0.38x | 11.08x |
| 2018 | $43.53 Billion | $131.54 Billion | $5.02 Billion | 0.33x | 8.66x |
| 2019 | $38.75 Billion | $120.07 Billion | $3.98 Billion | 0.32x | 9.73x |
| 2020 | $27.37 Billion | $121.98 Billion | $456.00 Million | 0.22x | 60.01x |
| 2021 | $37.17 Billion | $132.51 Billion | $2.54 Billion | 0.28x | 14.62x |
| 2022 | $27.88 Billion | $132.70 Billion | $4.34 Billion | 0.21x | 6.43x |
| 2023 | $20.89 Billion | $139.08 Billion | -$3.08 Billion | 0.15x | N/A |
| 2024 | $8.08 Billion | $147.66 Billion | -$8.64 Billion | 0.05x | N/A |
Competitor Companies of WBA by Market Capitalization
Companies near Walgreens Boots Alliance Inc in the global market cap rankings as of July 31, 2026.
Key companies related to Walgreens Boots Alliance Inc by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1566 globally with a market cap of $15.56 Billion USD ( €13.31 Billion EUR).
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2496 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3054 globally with a market cap of $6.26 Billion USD ( R$31.91 Billion BRL).
- Yifeng Pharmacy (SHG:603939): Ranked #4029 globally with a market cap of $4.03 Billion USD ( CN¥27.52 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1566 | JD HEALTH INTL LTD | F:8ZN | $15.56 Billion | €4.37 |
| #2496 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3054 | Raia Drogasil S.A | SA:RADL3 | $6.26 Billion | R$18.25 |
| #4029 | Yifeng Pharmacy | SHG:603939 | $4.03 Billion | CN¥22.70 |
Walgreens Boots Alliance Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Walgreens Boots Alliance Inc's market cap moved from $51.00 Billion to $ 10.37 Billion, with a yearly change of -15.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $10.37 Billion | +28.40% |
| 2024 | $8.08 Billion | -61.34% |
| 2023 | $20.89 Billion | -25.06% |
| 2022 | $27.88 Billion | -25.00% |
| 2021 | $37.17 Billion | +35.81% |
| 2020 | $27.37 Billion | -29.37% |
| 2019 | $38.75 Billion | -10.99% |
| 2018 | $43.53 Billion | -3.65% |
| 2017 | $45.18 Billion | -10.51% |
| 2016 | $50.49 Billion | -1.01% |
| 2015 | $51.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Jul 31st, 2026 the market cap of Walgreens Boots Alliance Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.37 Billion USD |
| MoneyControl | $10.37 Billion USD |
| MarketWatch | $10.37 Billion USD |
| marketcap.company | $10.37 Billion USD |
| Reuters | $10.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Walgreens Boots Alliance Inc
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy… Read more